2 active not recruiting, 2 completed, 1 recruiting. 3 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Low-Grade Squamous Intraepithelial Lesions: new trials by email Literature Review of Low-Grade Squamous Intraepithelial Lesions trials Research Report on Low-Grade Squamous Intraepithelial Lesions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV) Oral Immunomodulator, Vaginal Ovule, Standard Supportive Care - Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia (CIN) | Not applicable | Active not recruiting | Dr. Lutfi Kirdar Kartal Training and Research Hospital | 76 | 2026-04-28 | 2026-07-29 |
| Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection CO2 - HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions | Not applicable | Recruiting | First Affiliated Hospital of Wenzhou Medical University | 40 | 2023-09-11 | 2025-05-13 |
| Primary Cervical Cancer Screening by Self-sampling HPV Test Human Papillomavirus Infection, Cervical Cancer | Active not recruiting | Peking University People's Hospital | 17875 | 2022-11-19 | 2023-12-21 | |
| Effect of Alpha-lipoic Acid on Regression of Low-grade Squamous Intraepithelial Lesions (LSIL) DL-alpha lipoic acid, placebo (rice starch) - Low-Grade Squamous Intraepithelial Lesions | Not applicable | Completed | University of Zagreb | 100 | 2020-01-15 | 2022-08-03 |
| Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1) Aminolaevulinic acid, Placebo - Cervical Intraepithelial Neoplasia, Low-Grade Squamous Intraepithelial Lesions | Phase 2 | Completed | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 60 | 2016-03-22 | 2019-07-08 |
Squamous Intraepithelial Lesions (5) · Papillomavirus Infections (4) · Uterine Cervical Dysplasia (4) · Atypical Squamous Cells of the Cervix (2) · Adenocarcinoma in Situ (1) · Uterine Cervical Neoplasms (1)
Genital Diseases (5) · Morphological and Microscopic Findings (5) · Pathological Conditions, Signs and Symptoms (5) · Urogenital Diseases (5) · Communicable Diseases (4) · DNA Virus Infections (4) · Disease Attributes (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases, Female (4) · Infections (4) · Neoplasms (4) · Pathologic Processes (4) · Precancerous Conditions (4) · Sexually Transmitted Diseases (4)
5-aminolaevulinic acid-n-pentylester (1) · Immunologic Factors (1)
Dr. Lutfi Kirdar Kartal Training and Research Hospital (1) · First Affiliated Hospital of Wenzhou Medical University (1) · Peking University People's Hospital (1) · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1) · University of Zagreb (1)
China (3) · Bosnia and Herzegovina (1) · Croatia (1) · Turkey (Türkiye) (1)
Beihua Kong, MD (1) · Jining Tao (1) · Youzhong Zhang, MD (1)
PMID 19524035, PMID 23618600, PMID 26687616, PMID 29851256, PMID 30048762, PMID 30122563, PMID 30989655, PMID 32835877, PMID 33538338, PMID 35288319